InvestorsHub Logo
Followers 55
Posts 2608
Boards Moderated 0
Alias Born 02/04/2014

Re: frosr6 post# 37881

Wednesday, 07/01/2015 5:41:08 PM

Wednesday, July 01, 2015 5:41:08 PM

Post# of 144815
I think Dr Lohr addressed the fact that technology has advanced a lot since 2007 in the corporate video. He said they are able to do much more than in the past with all the new technological advancements. However, we are all anxious to hear that we have GMP approval. And that includes our CEO as he forthrightly mentioned in the Q&A. No one is walking around with blinders on. We understand the business and the challenges. Thanks for your well wishes.

4. The initiation of these three clinical trials is dependent on the approval for use of the Cell-in-a-Box® live cell encapsulation facility that has been constructed in Bangkok, Thailand, by our partner, Austrianova. This facility must be approved as being compliant with current Good Manufacturing Practices (cGMP) standards by Thailand’s and Australia’s drug regulatory authorities as well as by the U.S. FDA.

http://www.biomedreports.com/20150518222991/qaa-with-pharmacyte-ceo-kenneth-l-waggoner-on-pmcbs-new-direction.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News